Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.
2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10
52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,817 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,06,59351.5% delivered
Wockhardt board meetings
142 filed, newest first. Page 2 of 3.
Mar 2021
21 Mar · Board meeting
Not held on this date
Jan 2021
29 Jan · Board meeting
21 Jan · Board meeting
Nov 2020
2 Nov · Board meeting
Oct 2020
23 Oct · Board meeting
Aug 2020
29 Aug · Board meeting
19 Aug · Board meeting
May 2020
11 May · Board meeting
Feb 2020
12 Feb · Board meeting
Jan 2020
27 Jan · Board meeting
14 Jan · Board meeting
Nov 2019
7 Nov · Board meeting
Oct 2019
22 Oct · Board meeting
Aug 2019
14 Aug · Board meeting
Jul 2019
22 Jul · Board meeting
May 2019
6 May · Board meeting
Apr 2019
Jan 2019
28 Jan · Board meeting
14 Jan · Board meeting
Nov 2018
10 Nov · Board meeting
Oct 2018
Aug 2018
4 Aug · Board meeting
Jul 2018
18 Jul · Board meeting
May 2018
4 May · Board meeting
Apr 2018
18 Apr · Board meeting
Jan 2018
Oct 2017
Aug 2017
2 Aug · Board meeting
Jul 2017
May 2017
4 May · Board meeting
Apr 2017
Jan 2017
Nov 2016
10 Nov · Board meeting
Oct 2016
Aug 2016
Jul 2016
May 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Feb 2015
4 Feb · Board meeting
Jan 2015
23 Jan · Board meeting
Inter alia to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the third quarter and nine months ended December 31, 2014.
Oct 2014
21 Oct · Board meeting
Inter-alia to consider and approve for following matters : 1. To consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the second quarter and half year ended September 30, 2014. 2. To consider and recommend Interim Dividend, if any.
Sep 2014